The global breast ultrasound market is valued at USD 2.62 billion in 2025 and is projected to reach USD 8.67 billion by 2034, expanding at a strong CAGR of 14.21%. Market growth is driven by the rising prevalence of breast cancer, technological advancements such as AI-powered imaging, and growing preference for non-ionizing diagnostic techniques.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Breast Ultrasound Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Breast Ultrasound Market, by Product
8.1.1. Conventional Breast Ultrasound (CBUS)
8.1.1.1. Market Revenue and Forecast
8.1.2. Automated Breast Ultrasound (ABUS)
8.1.2.1. Market Revenue and Forecast
9.1. Breast Ultrasound Market, by End Use
9.1.1. Hospital
9.1.1.1. Market Revenue and Forecast
9.1.2. Diagnostics Imaging Laboratories
9.1.2.1. Market Revenue and Forecast
9.1.3. Others
9.1.3.1. Market Revenue and Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product
10.1.2. Market Revenue and Forecast, by End Use
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product
10.1.3.2. Market Revenue and Forecast, by End Use
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product
10.1.4.2. Market Revenue and Forecast, by End Use
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product
10.2.2. Market Revenue and Forecast, by End Use
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product
10.2.3.2. Market Revenue and Forecast, by End Use
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product
10.2.4.2. Market Revenue and Forecast, by End Use
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product
10.2.5.2. Market Revenue and Forecast, by End Use
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product
10.2.6.2. Market Revenue and Forecast, by End Use
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product
10.3.2. Market Revenue and Forecast, by End Use
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product
10.3.3.2. Market Revenue and Forecast, by End Use
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product
10.3.4.2. Market Revenue and Forecast, by End Use
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product
10.3.5.2. Market Revenue and Forecast, by End Use
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product
10.3.6.2. Market Revenue and Forecast, by End Use
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product
10.4.2. Market Revenue and Forecast, by End Use
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product
10.4.3.2. Market Revenue and Forecast, by End Use
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product
10.4.4.2. Market Revenue and Forecast, by End Use
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product
10.4.5.2. Market Revenue and Forecast, by End Use
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product
10.4.6.2. Market Revenue and Forecast, by End Use
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product
10.5.2. Market Revenue and Forecast, by End Use
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product
10.5.3.2. Market Revenue and Forecast, by End Use
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product
10.5.4.2. Market Revenue and Forecast, by End Use
11.1. GE HealthCare.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Koninklijke Philips N.V.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Siemens Healthineers AG
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. CANON MEDICAL SYSTEMS CORPORATION
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Telemed Medical Systems Srl
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Hologic, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. FUKUDA DENSHI
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Supersonic Imagine
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Lunit Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Delphinus Medical Technologies, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
13.1. About Us
13.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description